6
Oct
2026

DMG Italia Srl.

Exhibitor at CPHI Milan 2026 stand 18G57, Finished Dosage & Formulation
About Us

D.M.G. ITALIA S.R.L. is an Italian pharmaceutical company specialised in the research, development and marketing of Medical Devices and Food Supplements.

Since our foundation in 1993 we have been developing products, some of which patented in many different Countries, that have been studied by worldwide renowned Doctors. We take care of patients in and out of Europe, focusing on 4 main Therapeutic Areas: Gastroenterology, Ophthalmology, Otolaryngology and Paediatric.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Italy
  • On CPHI since:
    2020
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
Manufacturer/Innovator
OTC
Pharmaceutical company
Primary activities
Medical Devices
Nutraceuticals
OTC
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 18G57, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026

  • GASTROTUSS Line - Anti-Reflux Syrup & Tablets

    Product GASTROTUSS Line - Anti-Reflux Syrup & Tablets

    A complete Anti-Reflux Line against the symptoms of GERD, GER and EERD for Adults and Babies.

    Our Anti-Reflux Line is composed of:

    GASTROTUSS - ANTI-REFLUX SYRUP 
    Key Ingredients: Magnesium Alginate, Simethicone.

    GASTROTUSS - ANTI-REFLUX CHEWABLE TABLETS ...
  • OPHTHA OSD Line - ADVANCED CARE FOR EYES: THE POWER OF D.M.G. HYAL LINE

    Product OPHTHA OSD Line - ADVANCED CARE FOR EYES: THE POWER OF D.M.G. HYAL LINE

    SAFLOHYAL- IN CASE OF OCULAR INFLAMMATION
    Key Ingredients: Enoxolone glucuronide 2.5 %, Hyaluronic Acid Sodium Salt 0.10%, PEG/PPG (EG56) 1.5%.

    OFTAXHYAL- IN CASE OF CORNEAL INJURIES
    Key Ingredients: Hyaluronic Acid, Glycerylp...
  • NARIVENT NASAL SPRAY - A new direction in the Treatment of Inflammation - Antiedemigen Nasal Spray

    Product NARIVENT NASAL SPRAY - A new direction in the Treatment of Inflammation - Antiedemigen Nasal Spray

    Osmotically acting medical device with antiedemigen and phlogolitic effects.
    Narivent Anti-Edema Nasal Spray is an osmotically acting medical device with anti-edema and phlogolitic effect, indicated: • For the reduction of nasal obstruction in patients affected by nasal turbinate hypertrophy and b...
  • EMOFIX - The haemostatic barrier against bleeding episodes

    Product EMOFIX - The haemostatic barrier against bleeding episodes

    Emofix is an haemostatic ointment with barrier function indicated for the containment and prevention of cutaneous and mucosal haemorrhagic episodes such as, for example, essential, even slight, or traumatic epistaxis, small skin wounds, etc.
    • Performs an action of mechanical barrier; • Directl...
  • PANAVIRAL LINE - No room for Viruses and Bacteria

    Product PANAVIRAL LINE - No room for Viruses and Bacteria

    Panaviral Spray & Drops sanitizes and protects the nasal cavities from external agents, even of viral or bacterial origin. 
    • Helping to prevent the ability to spread of viruses and bacteria and to reduce cold symptoms; • Playing a defensing role in improving the innate antiviral...

D.M.G. ITALIA S.R.L. Resources (1)